Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SINTILIMAB vs SITAGLIPTIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SINTILIMAB vs SITAGLIPTIN: Safety Overview

Metric SINTILIMAB SITAGLIPTIN
Total FAERS Reports 652 19,904
Deaths Reported 61 2,412
Death Rate 9.4% 12.1%
Hospitalizations 225 6,668
Average Patient Age 57.6 yrs 67.3 yrs
% Female Patients 35.0% 52.3%
FDA Approval Date N/A Dec 30, 2025
Manufacturer N/A A-S Medication Solutions
Route N/A ORAL
Marketing Status N/A Prescription